Literature DB >> 26614595

Respiratory symptoms/diseases prevalence is still increasing: a 25-yr population study.

Sara Maio1, Sandra Baldacci2, Laura Carrozzi3, Francesco Pistelli3, Anna Angino2, Marzia Simoni2, Giuseppe Sarno2, Sonia Cerrai2, Franca Martini2, Martina Fresta2, Patrizia Silvi2, Francesco Di Pede2, Massimo Guerriero4, Giovanni Viegi5.   

Abstract

BACKGROUND: Few epidemiological surveys on general population samples estimated changes in prevalence of respiratory symptoms/diseases over a long time interval; our study aims to quantify the temporal changes in the prevalence rates of asthma, allergic rhinitis and Chronic Obstructive Pulmonary Disease (COPD) after 25 years from baseline.
METHODS: A general population sample participated in 3 cross-sectional surveys carried out in Central Italy (Pisa) in 1985-88 (n = 3865), 1991-93 (n = 2841), 2009-11 (n = 1620). 2276 (47%) subjects participated in at least 1 survey, 1723 (35.5%) in at least 2 surveys and 849 (17.5%) in all the 3 surveys. All subjects filled in a standardized questionnaire about health status and risk factors; a sub-sample performed spirometry. Chi-square test was used to compare adjusted prevalence rates of respiratory symptoms/diseases and descriptive characteristics among the surveys. Generalised estimating equations (GEE) were used to analyze the association between respiratory symptoms/diseases and risk factors.
RESULTS: There was an increasing trend in prevalence rates of all respiratory symptoms/diseases throughout the surveys: current asthma attacks (1st-3rd survey prevalence: 3.4-7.2%), allergic rhinitis (16.2-37.4%), usual phlegm (8.7-19.5%) and COPD (2.1-6.8%) more than doubled. The GEE model confirmed these increasing trends, indicating higher risk of having respiratory symptoms/diseases in the second and third surveys.
CONCLUSIONS: While asthma and allergic rhinitis increasing trends were confirmed, with respect to other international studies, also a COPD increasing prevalence rates was shown.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  General population; Prevalence trends; Risk factors

Mesh:

Year:  2015        PMID: 26614595     DOI: 10.1016/j.rmed.2015.11.006

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  21 in total

1.  Short-term effect of PM2.5 on pediatric asthma incidence in Shanghai, China.

Authors:  Yuxia Ma; Zhiang Yu; Haoran Jiao; Yifan Zhang; Bingji Ma; Fei Wang; Ji Zhou
Journal:  Environ Sci Pollut Res Int       Date:  2019-07-24       Impact factor: 4.223

Review 2.  Developmental origins of inflammatory and immune diseases.

Authors:  Ting Chen; Han-Xiao Liu; Hui-Yi Yan; Dong-Mei Wu; Jie Ping
Journal:  Mol Hum Reprod       Date:  2016-05-25       Impact factor: 4.025

3.  Mitochondrial ROS activate interleukin-1β expression in allergic rhinitis.

Authors:  Qiping Shi; Zhiwei Lei; Gui Cheng; Dehai Li; Qian Wang; Simin Luo; Hengwen Yang; Haiying Jia
Journal:  Oncol Lett       Date:  2018-06-18       Impact factor: 2.967

4.  Classification and treatment of chronic obstructive pulmonary disease outpatients in China according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017: comparison with GOLD 2014.

Authors:  Yanan Cui; Zhongshang Dai; Lijuan Luo; Ping Chen; Yan Chen
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

5.  From the Global Initiative for Asthma report and asthma guidelines to real-life asthma control: is there room for improvement?

Authors:  Elio Novembre; Mattia Giovannini; Simona Barni; Francesca Mori
Journal:  Ital J Pediatr       Date:  2022-07-05       Impact factor: 3.288

Review 6.  Exposomic determinants of immune-mediated diseases: Special focus on type 1 diabetes, celiac disease, asthma, and allergies: The HEDIMED project approach.

Authors:  Jutta E Laiho; Olli H Laitinen; Johannes Malkamäki; Leena Puustinen; Aki Sinkkonen; Juha Pärkkä; Heikki Hyöty
Journal:  Environ Epidemiol       Date:  2022-06-08

7.  Cold weather increases respiratory symptoms and functional disability especially among patients with asthma and allergic rhinitis.

Authors:  Henna Hyrkäs-Palmu; Tiina M Ikäheimo; Tiina Laatikainen; Pekka Jousilahti; Maritta S Jaakkola; Jouni J K Jaakkola
Journal:  Sci Rep       Date:  2018-07-04       Impact factor: 4.379

8.  Maternal Glucocorticoid Elevation and Associated Fetal Thymocyte Apoptosis are Involved in Immune Disorders of Prenatal Caffeine Exposed Offspring Mice.

Authors:  Han-Xiao Liu; Ting Chen; Xiao Wen; Wen Qu; Sha Liu; Hui-Yi Yan; Li-Fang Hou; Jie Ping
Journal:  Sci Rep       Date:  2017-10-23       Impact factor: 4.379

9.  Characteristics of COPD patients according to GOLD classification and clinical phenotypes in the Russian Federation: the SUPPORT trial.

Authors:  Vladimir Arkhipov; Daria Arkhipova; Marc Miravitlles; Andrey Lazarev; Ekaterina Stukalina
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-11-03

10.  Prevalence of asthma-like symptoms with ageing.

Authors:  Debbie Jarvis; Roger Newson; Christer Janson; Angelo Corsico; Joachim Heinrich; Josep M Anto; Michael J Abramson; Anne-Marie Kirsten; Jan Paul Zock; Roberto Bono; Pascal Demoly; Bénédicte Leynaert; Chantal Raherison; Isabelle Pin; Thorarinn Gislason; Rain Jogi; Vivi Schlunssen; Cecilie Svanes; John Watkins; Joost Weyler; Antonio Pereira-Vega; Isabel Urrutia; Jose A Gullón; Bertil Forsberg; Nicole Probst-Hensch; H Marike Boezen; Jesús Martinez-Moratalla Rovira; Simone Accordini; Roberto de Marco; Peter Burney
Journal:  Thorax       Date:  2017-10-03       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.